Literature DB >> 18040676

Evaluation of postoperative pulmonary regurgitation after surgical repair of tetralogy of Fallot: comparison between Doppler echocardiography and MR velocity mapping.

Matthias Grothoff1, Birgit Spors, Hasim Abdul-Khaliq, Matthias Gutberlet.   

Abstract

BACKGROUND: Pulmonary regurgitation is a common finding in patients after correction of tetralogy of Fallot (TOF). Right ventricular impairment and even ventricular arrhythmia have been ascribed to pulmonary valve insufficiency (PI), which is therefore an important issue in follow-up examinations.
OBJECTIVE: To compare PI measured by echocardiography (ECHO) with data provided by cardiac MRI (CMR).
MATERIALS AND METHODS: We studied 54 selected patients (18 female; median age 14.0 years, range 3.8-53.4 years) after surgical correction of TOF. To quantify pulmonary regurgitant fraction (PRF) by CMR, flow velocity mapping was performed. On Doppler ECHO, length, width and localization of regurgitant flow was measured. The severity of PI was categorized as mild, moderate or severe and compared to the data obtained by CMR.
RESULTS: On CMR the mean PRF was 29.2 +/- 13.4%. Patients with a transannular patch had a significantly higher PRF (39.9 +/- 11.6%) than patients with an intact annular ring (23.6 +/- 11.4%). Differentiation by Doppler ECHO between the categories mild, moderate and severe PI was confirmed by significant differences in PRF measured by CMR (mild vs. moderate P < 0.04; moderate vs. severe P < 0.014; mild vs. severe P < 0.001). Furthermore, PRF correlated with right ventricular end diastolic volume index (r = 0.45, P < 0.01) and right ventricular end systolic volume index (r = 0.39, P < 0.01).
CONCLUSION: Doppler ECHO can estimate the severity of PI after repair of TOF with acceptable results compared to CMR flow measurement. In univariate analysis there is only a weak influence of PRF on right ventricular volume.

Entities:  

Mesh:

Year:  2007        PMID: 18040676     DOI: 10.1007/s00247-007-0691-y

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  19 in total

1.  Arterial switch procedure for D-transposition of the great arteries: quantitative midterm evaluation of hemodynamic changes with cine MR imaging and phase-shift velocity mapping-initial experience.

Authors:  M Gutberlet; T Boeckel; N Hosten; M Vogel; T Kühne; H Oellinger; T Ehrenstein; S Venz; R Hetzer; G Bein; R Felix
Journal:  Radiology       Date:  2000-02       Impact factor: 11.105

2.  Corrected tetralogy of Fallot: delayed enhancement in right ventricular outflow tract.

Authors:  Thomas Oosterhof; Barbara J M Mulder; Hubert W Vliegen; Albert de Roos
Journal:  Radiology       Date:  2005-12       Impact factor: 11.105

Review 3.  Right ventricular function in congenital heart disease: pressure and volume overload lesions.

Authors:  M A Fogel; J Rychik
Journal:  Prog Cardiovasc Dis       Date:  1998 Jan-Feb       Impact factor: 8.194

4.  Relationship between type of outflow tract repair and postoperative right ventricular diastolic physiology in tetralogy of Fallot. Implications for long-term outcome.

Authors:  G Norgård; M A Gatzoulis; F Moraes; C Lincoln; D F Shore; E A Shinebourne; A N Redington
Journal:  Circulation       Date:  1996-12-15       Impact factor: 29.690

5.  Measurement of flow with NMR imaging using a gradient pulse and phase difference technique.

Authors:  D J Bryant; J A Payne; D N Firmin; D B Longmore
Journal:  J Comput Assist Tomogr       Date:  1984-08       Impact factor: 1.826

6.  Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study.

Authors:  M A Gatzoulis; S Balaji; S A Webber; S C Siu; J S Hokanson; C Poile; M Rosenthal; M Nakazawa; J H Moller; P C Gillette; G D Webb; A N Redington
Journal:  Lancet       Date:  2000-09-16       Impact factor: 79.321

7.  Pulmonary regurgitation in the late postoperative follow-up of tetralogy of Fallot. Volumetric quantitation by nuclear magnetic resonance velocity mapping.

Authors:  S A Rebergen; J G Chin; J Ottenkamp; E E van der Wall; A de Roos
Journal:  Circulation       Date:  1993-11       Impact factor: 29.690

8.  Right ventricular dysfunction and pulmonary valve replacement after correction of tetralogy of Fallot.

Authors:  Frank T H de Ruijter; Ineke Weenink; Francois J Hitchcock; Erik J Meijboom; Ger B W E Bennink
Journal:  Ann Thorac Surg       Date:  2002-06       Impact factor: 4.330

9.  Routine primary repair of tetralogy of Fallot in neonates and infants less than three months of age.

Authors:  V M Reddy; J R Liddicoat; D B McElhinney; M M Brook; P Stanger; F L Hanley
Journal:  Ann Thorac Surg       Date:  1995-12       Impact factor: 4.330

10.  Intermediate results after complete repair of tetralogy of Fallot in neonates.

Authors:  H A Hennein; R S Mosca; G Urcelay; D C Crowley; E L Bove
Journal:  J Thorac Cardiovasc Surg       Date:  1995-02       Impact factor: 5.209

View more
  14 in total

1.  Calculations of cardiovascular shunts and regurgitation using magnetic resonance ventricular volume and aortic and pulmonary flow measurements.

Authors:  Daniel G H Devos; Philip J Kilner
Journal:  Eur Radiol       Date:  2009-08-29       Impact factor: 5.315

2.  Correlation of pulmonary regurgitation fraction and right ventricular ejection fraction in patients with tetralogy of Fallot.

Authors:  Martin Koestenberger; Bert Nagel; Verena Halb; Andreas Gamillscheg
Journal:  Clin Res Cardiol       Date:  2011-03-24       Impact factor: 5.460

3.  Effects of pulmonary regurgitation on distensibility and flow of the branch pulmonary arteries in tetralogy of Fallot.

Authors:  Eva M Voser; Christian J Kellenberger; Emanuela R Valsangiacomo Buechel
Journal:  Pediatr Cardiol       Date:  2013-01-06       Impact factor: 1.655

Review 4.  Right heart dilatation in adult congenital heart disease: imaging appearance on cardiac magnetic resonance.

Authors:  D Beitzke; F Wolf; G Edelhauser; J Lammer; C Loewe
Journal:  Br J Radiol       Date:  2010-12-15       Impact factor: 3.039

5.  Time course of right ventricular functional parameters after surgical correction of tetralogy of Fallot determined by cardiac magnetic resonance.

Authors:  M Grothoff; J Hoffmann; L Lehmkuhl; H Abdul-Khaliq; S Nitzsche; A Mahler; I Dähnert; F Berger; M Gutberlet
Journal:  Clin Res Cardiol       Date:  2010-11-19       Impact factor: 5.460

6.  Qualitative echocardiographic assessment of aortic valve regurgitation with quantitative cardiac magnetic resonance: a comparative study.

Authors:  Shelby Kutty; Kevin K Whitehead; Shobha Natarajan; Matthew A Harris; Gil Wernovsky; Mark A Fogel
Journal:  Pediatr Cardiol       Date:  2009-07-28       Impact factor: 1.655

Review 7.  Choosing Between MRI and CT Imaging in the Adult with Congenital Heart Disease.

Authors:  Crystal Bonnichsen; Naser Ammash
Journal:  Curr Cardiol Rep       Date:  2016-05       Impact factor: 2.931

8.  Value of cardiovascular MR in diagnosing left ventricular non-compaction cardiomyopathy and in discriminating between other cardiomyopathies.

Authors:  Matthias Grothoff; Milena Pachowsky; Janine Hoffmann; Maximilian Posch; Sabine Klaassen; Lukas Lehmkuhl; Matthias Gutberlet
Journal:  Eur Radiol       Date:  2012-07-10       Impact factor: 5.315

9.  Pulmonary regurgitant volume is superior to fraction using background-corrected phase contrast MRI in determining the severity of regurgitation in repaired tetralogy of Fallot.

Authors:  Thomas M Gorter; Joost P van Melle; Hendrik G Freling; Tjark Ebels; Beatrijs Bartelds; Petronella G Pieper; Rolf M F Berger; Dirk J van Veldhuisen; Tineke P Willems
Journal:  Int J Cardiovasc Imaging       Date:  2015-05-06       Impact factor: 2.357

Review 10.  2014 Korean guidelines for appropriate utilization of cardiovascular magnetic resonance imaging: a joint report of the Korean Society of Cardiology and the Korean Society of Radiology.

Authors:  Yeonyee E Yoon; Yoo Jin Hong; Hyung-Kwan Kim; Jeong A Kim; Jin Oh Na; Dong Hyun Yang; Young Jin Kim; Eui-Young Choi
Journal:  Korean J Radiol       Date:  2014-11-07       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.